Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Pharmacological Research|February 14, 2021
Whole transcriptome sequencing and integrated network analysis elucidates the effects of 3,8-Di-O-methylellagic acid 2-O-glucoside derived from Sanguisorba offcinalis L., a novel differentiation inducer on erythroleukemia cellsWang Long, Sha Liu, Xiao-Xuan Li, et al.
Scientific Reports|October 31, 2015
Amiodarone as an autophagy promoter reduces liver injury and enhances liver regeneration and survival in mice after partial hepatectomyChih-Wen Lin, Yaw-Sen Chen, Chih-Che Lin, et al.
Toxins|January 6, 2018
ROS-Mediated Cell Cycle Arrest and Apoptosis Induced by Zearalenone in Mouse Sertoli Cells via ER Stress and the ATP/AMPK PathwayWang-Long Zheng, Bing-Jie Wang, Ling Wang, et al.
Oncotarget|December 2, 2017
The autophagy marker LC3 strongly predicts immediate mortality after surgical resection for hepatocellular carcinomaChih-Wen Lin, Chih-Che Lin, Po-Huang Lee, et al.
Frontiers in Immunology|August 1, 2022
NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancerXiao-Yang Gong, Hai-Bin Chen, Li-Qing Zhang, et al.
Nature Communications|March 11, 2023
Clinical and biomarker analyses of sintilimab plus gemcitabine and cisplatin as first-line treatment for patients with advanced biliary tract cancerTian-Mei Zeng, Guang Yang, Cheng Lou, et al.
Hepatology International|May 28, 2016
APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testingMasao Omata, Tatsuo Kanda, Lai Wei, et al.
Hepatology International|May 1, 2016
APASL consensus statements and recommendation on treatment of hepatitis CMasao Omata, Tatsuo Kanda, Lai Wei, et al.
Hepatology International|December 13, 2018
APASL clinical practice recommendation: how to treat HCV-infected patients with renal impairment?Tatsuo Kanda, George K K Lau, Lai Wei, et al.
Hepatology International|September 22, 2019
APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivationTatsuo Kanda, George K K Lau, Lai Wei, et al.
Pageof 7